Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1 1

Status

Completed 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Pancreatic Neoplasms 4Pancreatic Intraductal Neoplasms 2

Interventions

tocotrienol, delta 2Surgical Procedures, Operative 2Paclitaxel 2Erlotinib Hydrochloride 2dehydroftorafur 1dachengqi decoction 1X-Rays 1Tomography, Optical Coherence 1Therapeutic Irrigation 1Surveys and Questionnaires 1Sulindac 1Specimen Handling 1Secretin 1Saline Solution 1Radiotherapy, Intensity-Modulated 1Radiotherapy, Conformal 1Phantoms, Imaging 1Pancreatectomy 1Octreotide 1Magnetic Resonance Spectroscopy 1Liquid Biopsy 1Immunohistochemistry 1Hydrocortisone 1Gemcitabine 1Fluorouracil 1Ferrosoferric Oxide 1Ethanol 1Endosonography 1Endoscopic Ultrasound-Guided Fine Needle Aspiration 1Drug Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Pancreatic Intraductal Neoplasms × tocotrienol, delta × Clear all
NCT06519097 2025-11-13

Study of IPMN Progression Prevention With Tocotrienol (SIPP-T3)

H. Lee Moffitt Cancer Center and Research Institute

Phase 2 Active not recruiting
4 enrolled
Gastrointestinal

Pancreatic Intraductal Neoplasms, Pancreatic Neoplasms

NCT00985777 2016-03-01

Vitamin E δ-Tocotrienol Administered to Subjects With Resectable Pancreatic Exocrine Neoplasia

H. Lee Moffitt Cancer Center and Research Institute

Phase 1 Completed
26 enrolled
Gastrointestinal

Pancreatic Intraductal Neoplasms, Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡